Skip to main content
. 2017 May 4;7(4):e012652. doi: 10.1136/bmjopen-2016-012652

Table 3.

Base-case results for different pretest probabilities. Dominated strategies not shown, except when significant uncertainty regarding dominance on sensitivity analysis

Pretest probability Strategy Avg cost per patient (I$) C-E
(I$/diag)
ICER
(I$/diag)
Accuracy (%) FN
(%)
Deaths (%) Invasive CA (%) Negative invasive CA (%)
Low 2 (Ex-ECG→CTA → CA) 125 135 - 93 7.4 0.009 18 5
1 (Ex-ECG → ECHO → CA) 141 153 - 92 7.6 0.012 25 12
9 (CTA → CA) 197 202 1420* 98 2.4 0.007 29 12
8 (C-MRI → CA) 315 322 47 800† 98 2.1 0.008 37 19
Moderate 2 (Ex-ECG → CTA → CA) 188 231 - 81 18.5 0.013 35 3
4 (Ex-ECG → CA) 205 240 415‡ 86 14.3 0.017 58 23
9 (CTA → CA) 269 286 750§ 94 5.9 0.011 51 7
6 (ECHO → CA) 286 305 - 94 6.4 0.017 61 17
8 (C-MRI → CA) 385 407 17 800† 95 5.2 0.012 57 12
High 4 (Ex-ECG → CA) 222 278 - 80 20.1 0.018 63 14
9 (CTA → CA) 317 345 790§ 92 8.2 0.014 66 4
6 (ECHO → CA) 320 351 - 91 8.9 0.019 71 10
10 (CA → ECHO) 373 381 273† 98 1.7 0.02 100 30

*ICER vs strategy 1.

†ICER vs strategy 9.

‡ICER vs strategy 2.

§ICER vs strategy 4.

Avg, average; CA, invasive coronary angiography; C-E, cost-effectiveness; C-MRI, cardiac MRI;  CTA, CT coronary angiogram; ECHO, stress echocardiogram; Ex-ECG, exercise ECG; FN, false-negative; ICER, incremental cost-effectiveness ratio.